Mount Sinai Hospital
Program Manager I - Tisch Cancer Institute
Mount Sinai Hospital - New York, New York, United States, 10001
Work at Mount Sinai Hospital
Overview
- View job
Overview
Program Manager I
The Program Manager I (PM) is responsible for providing administrative, operational and programmatic oversight of the Protocol Review and Monitoring System. The PM is responsible for all ensuring that all cancer-related clinical research receives appropriate peer-review prior to activation and then regular monitoring for scientific progress. The Program Manager will have a thorough knowledge of institutional, PRMC policies and procedures and National Cancer Institute (NCI) guidelines related to cancer clinical trials. The PM coordinates all activities of the scientific committees (disease focus groups, protocol review and monitoring committees), including scheduling meetings, preparing agendas and meeting materials, and documenting minutes. The PM manages the intake process, and all correspondences with Principal Investigators regarding protocol approvals, amendments, and stipulations. The PM execute decisions regarding expedited approval and studies needing administrative approval. The PM facilitates compliant documentation and capture of clinical trials data within our clinical trials management system (OnCore). The PM is instrumental in developing program policies, procedures, workflows and tools that promote operational efficiency and is responsible for producing routine metric reports for leadership evaluation. The PM is accountable to the PRMS Chairs, PRMS Director and reports to the Executive Director, Enterprise Cancer Clinical Research.
The Program Manager I (PM) is responsible for providing administrative, operational and programmatic oversight of the Protocol Review and Monitoring System. The PM is responsible for all ensuring that all cancer-related clinical research receives appropriate peer-review prior to activation and then regular monitoring for scientific progress. The Program Manager will have a thorough knowledge of institutional, PRMC policies and procedures and National Cancer Institute (NCI) guidelines related to cancer clinical trials. The PM coordinates all activities of the scientific committees (disease focus groups, protocol review and monitoring committees), including scheduling meetings, preparing agendas and meeting materials, and documenting minutes. The PM manages the intake process, and all correspondences with Principal Investigators regarding protocol approvals, amendments, and stipulations. The PM execute decisions regarding expedited approval and studies needing administrative approval. The PM facilitates compliant documentation and capture of clinical trials data within our clinical trials management system (OnCore). The PM is instrumental in developing program policies, procedures, workflows and tools that promote operational efficiency and is responsible for producing routine metric reports for leadership evaluation. The PM is accountable to the PRMS Chairs, PRMS Director and reports to the Executive Director, Enterprise Cancer Clinical Research.